HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use
about
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report.Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru.HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City.Drug treatment as HIV prevention: a research updateDrug treatment as HIV prevention: expanding treatment options.The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons.Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.Distress tolerance and use of antiretroviral therapy among HIV-infected individuals in substance abuse treatment.Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.Substance use: impact on adherence and HIV medical treatment.Neighborhood Characteristics Associated with Achievement and Maintenance of HIV Viral Suppression Among Persons Newly Diagnosed with HIV in New York City.Alcohol and substance use diagnoses among HIV-positive patients receiving care in NYC clinic settings.Understanding Determinants of Racial and Ethnic Disparities in Viral Load Suppression.Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs.Antiretroviral Therapy Outcomes in Patients with Severe Mental Illness.Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factorsA window of opportunity: maximizing the effectiveness of new HCV regimens in the United States with the expansion of the Affordable Care Act.
P2860
Q28535233-34225C58-B566-414F-8D6D-EE482B42029DQ33660210-9D387C29-B282-4501-9D0E-CEA5E40ABF9CQ34244681-5EEC5FE5-0288-49BA-B145-25B0FF3F4C0CQ34458805-E0E87F20-0890-40E4-AAFD-52329BD5CA80Q34735495-4D492826-51AA-46B7-AC74-9762931EFF02Q35163392-956A1EFA-6552-4943-B5BD-4F107213595DQ35163396-C675951E-5EFA-4CA3-8E87-52D40E721083Q35804426-7CFB3A3D-F415-4BD8-AB6B-D1428C58D0ECQ35823204-6BF60550-536D-48EE-A292-5AE44527C38CQ35911178-6330256B-2975-4C29-9D47-B75A5B43CCC5Q36696253-B915A90A-0E68-4304-A2A3-591298D27EC9Q36853880-86DEEC72-BEE8-4A03-9D07-A8A21BC084F0Q37139547-F87A517F-0159-446C-8197-C829BFF67435Q37499070-98BED850-FE31-4EB5-A646-4679C046A254Q37920746-16A635E3-CC39-4DB9-808E-CADB14E42F2AQ38979755-06214F6A-DA7F-4909-BB68-40452E3F3E24Q40053532-41D42B97-09E4-45C5-B955-FBCD3F3EFBDAQ40581238-D329E9A3-185D-43D0-8BE1-8CC99754DF86Q40893302-E2243970-C96C-4E89-AA9C-2F6548E097B7Q41108558-55F79045-F256-4EA0-88B9-6526E3FD7E94Q41151678-180C9A05-F332-4FD2-9035-D9930739A45CQ52306466-F9324BD5-72F3-4592-8407-26E7DDD4F262
P2860
HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HAART receipt and viral suppre ...... l illness and illicit drug use
@en
HAART receipt and viral suppre ...... illness and illicit drug use.
@nl
type
label
HAART receipt and viral suppre ...... l illness and illicit drug use
@en
HAART receipt and viral suppre ...... illness and illicit drug use.
@nl
prefLabel
HAART receipt and viral suppre ...... l illness and illicit drug use
@en
HAART receipt and viral suppre ...... illness and illicit drug use.
@nl
P2093
P2860
P1433
P1476
HAART receipt and viral suppre ...... l illness and illicit drug use
@en
P2093
Geetanjali Chander
James Hellinger
John A Fleishman
Kelly A Gebo
Paul Gaist
Richard D Moore
Seth Himelhoch
P2860
P304
P356
10.1080/09540120802459762
P577
2009-05-01T00:00:00Z